Engineered cytotoxic ribonuclease A

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435196, 435199, 935 10, A61K 3846, C12N 916, C12N 922

Patent

active

058402969

ABSTRACT:
Modified ribonucleases belonging to the RNase A superfamily of ribonucleases is disclosed. Each modified ribonuclease has a mutation in the loop region corresponding to amino acids 85-94 of bovine pancreatic RNase A. Each modified ribonuclease has reduced binding affinity for ribonuclease inhibitor (RI), wild-type ribonuclease activity, and exhibits enhanced cytotoxicity toward tumor cells, relative to the wild-type ribonuclease. Also disclosed is a method for obtaining a modified ribonuclease having reduced binding affinity for RI, wild-type ribonuclease activity, and enhanced cytotoxicity.

REFERENCES:
patent: 5389537 (1995-02-01), Raines et al.
Alfacell Corporation, Reports and Press Releases from Oct. 1994-Nov. 1996.
Delmonte, "Novel Ribonuclease Shows Antitumor Activity in Pancreatic Cancer and Mesothelioma", Onclology Times 18 No. 6, 1996.
Kim et al., "Mechanism of Ribonuclease Cytotoxicity", J. Biol. Chem. 270 No. 52: 31097-31102, 1995.
Kim et al., "Structural Basis for the Biological Activities of Bovine Seminal Ribonuclease", J. Biol. Chem. 270, No. 18: 10525-10530, 1995.
Kobe and Deisenhofer, "A Structural Basis of the Interactions Between Leucine-Rich Repeats and Protein Ligands", Nature 374, No. 9: 183-186, 1995.
Raines et al., "Replacing a Surface Loop Endows Ribonuclease A with Angiogenic Activity", J. Biol. Chem. 270, No. 29: 17180-17184, 1995.
Schein, "From Housekeeper to Microsurgeon: The Diagnostic and Therapeutic Potential of Ribonucleases", Nature Biotechnology 15: 529-536, 1997.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Engineered cytotoxic ribonuclease A does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Engineered cytotoxic ribonuclease A, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Engineered cytotoxic ribonuclease A will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1699148

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.